17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
What happens when legislative efforts are met with focused pressure from a variety of industries, ci...
Read More >
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announc...
Read More >
On the final day of the 2019 legislative session, Oregon approved Senate Bill 2005, the Oregon Famil...
Read More >
In 1980, Congress enacted the Comprehensive Environmental Response, Compensation, and Liability Act ...
Read More >
In this OnPoint, we report on a recent decision of the UK Employment Appeal Tribunal on the issue of...
Read More >
Congress recently passed the economic stimulus package referred to as the Coronavirus Aid, Relief, a...
Read More >